TaP Pharmaceuticals AG
9Patents
5Active
9Granted
48Portfolio score
Filing activity: Jul 10, 1990 → Apr 11, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5140009A | Octapeptide LHRH antagonists | Human Necessities | 34 | Expired |
| US5300492A | LHRH analogs | Human Necessities | 20 | Expired |
| US5413990A | N-terminus modified analogs of LHRH | Chemistry; Metallurgy | 16 | Expired |
| US5534548A | Method of treating preeclampsia | Human Necessities | 2 | Expired |
| US11980685B1 | Liquid pharmaceutical formulations of tafamidis | Human Necessities | 0 | Active |
| US11833138B1 | Liquid pharmaceutical formulations of apixaban | Human Necessities | 0 | Active |
| US12042491B1 | Pharmaceutical formulations of quinolines | Emerging Cross-Sectional Technologies | 0 | Active |
| US12290504B2 | Aqueous formulations of topiramate | Human Necessities | 0 | Active |
| US11878081B1 | Pharmaceutical formulations of tafamidis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.